Open AccessPredictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19
Author(s) -
Yan Li,
Shuang Yang,
Pingyu Ding,
Hongming Zhu,
Bangyi Li,
Xiaojiao Yang,
Xuelian Sun,
Mei Zhang
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i20.4726
Subject(s) - medicine , cystatin c , creatinine , renal function , acute kidney injury , proportional hazards model , lactate dehydrogenase , gastroenterology , biochemistry , chemistry , enzyme
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. COVID-19 is clinically categorized into mild, moderate, severe, and critical illness. Acute kidney injury is an independent risk factor for poor prognosis in patients with. Serum cystatin C (sCys C) is considered a more sensitive biomarker for early renal insufficiency than conventional indicators of renal function. Early detection of risk factors that affect the prognosis of severe and critically ill patients while using active and effective treatment measures is very important and can effectively reduce the potential mortality rate.